Norpace Cr Capsule, Extended Release
Product Images NDC 0025-2732

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norpace Cr (NDC 0025-2732). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Norpace 01)

The text is not-available as it lacks context and is composed solely of chemical symbols and formulas. It appears to be a diagram of a chemical structure, but without more information, it cannot be interpreted or described.*

FDA Label Image

G.d. Searle Llc Logo (Norpace 02)

This text indicates that the distribution of a product is being handled by Pfizer Labs, which is a division of Pfizer Inc. The location of the division is in NY, NY 10017.*

FDA Label Image

Principle Display Panel (100 mg Bottle Label)

This is a medication with the brand name Norpace® and the active ingredient disopyramide phosphate. The medication comes in a capsule form with each capsule containing 100 mg of the active ingredient. The recommended storage temperature is between 15-30°C (50-86°F), while the permissible temperature range is within 25°C (17°F). The manufacturer is Pfizer Labs and the medication is distributed from New York. The text also includes a product code (NDC 0025-2752-31) and a lot number (PAA164018). No dosage or usage information is provided, and the text contains several typographical errors.*

FDA Label Image

Principle Display Panel (150 mg Bottle Label)

Store the disopyramide phosphate capsules USP at a temperature of 25°C (17°F). Excursions pemmitied o 15-30°C (50-86°F). Refer to USP Controlled Room Temperature]. The capsules are available in 100 capsules Rx only. Each capsule contains 150 mg of dopytaids bas. See accompanying prescribing information for dosage and use. The containers are distributed by PizerLabs, Dison ofPizer e, Y, NY 10017. The product is made in Japan. The NDC number for this product is 0025-2762-31.*

FDA Label Image

Principle Display Panel (100 mg Bottle Label)

This is a medication for Norpace® CR, which contains disopyramide phosphate extended-release capsules USP2 with a strength of 100mg. The medication should be stored in a cool, dry, tight and chi-resistant container with temperature excursions permitted to 15-30°C (50-86°F). Dosage and usage information can be found in the accompanying information. The medication is distributed by Pfizer and made in Japan. The product is contained in a bottle with 100 capsules, and lot/expiry information and GTIN number are not available from the given text.*

FDA Label Image

Principle Display Panel (150 mg Bottle Label)

This text provides some storage information as well as some dosage and use instructions for a medication called Norpace CR. Each capsule is said to contain 150 mg of disopyramide phosphate and the medication comes in extended-release capsules. The text also includes contact information for Pfizer Labs.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.